Genetic engineering to enhance microalgal-based produced water treatment with emphasis on CRISPR/Cas9: A review

被引:14
|
作者
Hassanien, Alaa [1 ]
Saadaoui, Imen [1 ,2 ]
Schipper, Kira [1 ]
Al-Marri, Sara [3 ]
Dalgamouni, Tasneem [1 ]
Aouida, Mustapha [4 ]
Saeed, Suhur [3 ]
Al-Jabri, Hareb M. M. [1 ,2 ]
机构
[1] Qatar Univ, Coll Arts & Sci, Ctr Sustainable Dev, Algal Technol Program, Doha, Qatar
[2] Qatar Univ, Coll Arts & Sci, Biol & Environm Sci Dept, Doha, Qatar
[3] ExxonMobil Res Qatar EMRQ, Doha, Qatar
[4] Hamad Bin Khalifa Univ, Qatar Fdn, Coll Hlth & Life Sci, Div Biol & Biomed Sci,Educ City, Doha, Qatar
关键词
bioremediation; CRISPR; cas9; genetic engineering; microalgae; produced wastewater; WASTE-WATER; RANDOM MUTAGENESIS; MANNOSYLERYTHRITOL LIPIDS; CHLAMYDOMONAS-REINHARDTII; FIELD RELEASE; BIOREMEDIATION; IMPROVEMENT; CULTIVATION; HEAVY; TALEN;
D O I
10.3389/fbioe.2022.1104914
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In recent years, the increased demand for and regional variability of available water resources, along with sustainable water supply planning, have driven interest in the reuse of produced water. Reusing produced water can provide important economic, social, and environmental benefits, particularly in water-scarce regions. Therefore, efficient wastewater treatment is a crucial step prior to reuse to meet the requirements for use within the oil and gas industry or by external users. Bioremediation using microalgae has received increased interest as a method for produced water treatment for removing not only major contaminants such as nitrogen and phosphorus, but also heavy metals and hydrocarbons. Some research publications reported nearly 100% removal of total hydrocarbons, total nitrogen, ammonium nitrogen, and iron when using microalgae to treat produced water. Enhancing microalgal removal efficiency as well as growth rate, in the presence of such relevant contaminants is of great interest to many industries to further optimize the process. One novel approach to further enhancing algal capabilities and phytoremediation of wastewater is genetic modification. A comprehensive description of using genetically engineered microalgae for wastewater bioremediation is discussed in this review. This article also reviews random and targeted mutations as a method to alter microalgal traits to produce strains capable of tolerating various stressors related to wastewater. Other methods of genetic engineering are discussed, with sympathy for CRISPR/Cas9 technology. This is accompanied by the opportunities, as well as the challenges of using genetically engineered microalgae for this purpose.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Optimization of tissue culture and Cas9 transgene expression in tomato: A step towards CRISPR/Cas9-based genetic improvement
    Kaul, Rashmi
    Thangaraj, Arulprakash
    Sharda, Shivani
    Kaul, Tanushri
    PLANT SCIENCE, 2025, 352
  • [22] Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead
    Jena, Radheshyam
    Vishwas, Sukriti
    Kumar, Rajan
    Kaur, Jaskiran
    Khursheed, Rubiya
    Gulati, Monica
    Singh, Thakur Gurjeet
    Vanathi, B. Meenashi
    Alam, Aftab
    Kumar, Bimlesh
    Chaitanya, M. V. N. L.
    Gupta, Saurabh
    Negi, Poonam
    Pandey, Narendra Kumar
    Bhatt, Shvetank
    Gupta, Gaurav
    Chellappan, Dinesh Kumar
    Oliver, Brian G.
    Dua, Kamal
    Singh, Sachin Kumar
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 931
  • [23] A CRISPR/Cas9 based engineering strategy for overexpression of multiple genes in Chinese hamster ovary cells
    Eisenhut, Peter
    Klanert, Gerald
    Weinguny, Marcus
    Baier, Laurenz
    Jadhav, Vaibhav
    Ivansson, Daniel
    Borth, Nicole
    METABOLIC ENGINEERING, 2018, 48 : 72 - 81
  • [24] A CRISPR/Cas9 based engineering strategy for overexpression of multiple genes in Chinese hamster ovary cells
    Eisenhut, P.
    Klanert, G.
    Weinguny, M.
    Baier, L.
    Jadhav, V.
    Ivansson, D.
    Borth, N.
    NEW BIOTECHNOLOGY, 2018, 44 : S145 - S145
  • [25] CRISPR/Cas9 in the treatment of sickle cell disease (SCD) and its comparison with traditional treatment approaches: a review
    Tariq, Hamza
    Khurshid, Fatima
    Khan, Muhammad Hamza
    Dilshad, Aamna
    Zain, Ahmad
    Rasool, Warda
    Jawaid, Alishba
    Kunwar, Digbijay
    Khanduja, Sneha
    Akbar, Anum
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (10): : 5938 - 5946
  • [26] A Critical Review: Recent Advancements in the Use of CRISPR/Cas9 Technology to Enhance Crops and Alleviate Global Food Crises
    Rasheed, Adnan
    Gill, Rafaqat Ali
    Hassan, Muhammad Umair
    Mahmood, Athar
    Qari, Sameer
    Zaman, Qamar U.
    Ilyas, Muhammad
    Aamer, Muhammad
    Batool, Maria
    Li, Huijie
    Wu, Ziming
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (03) : 1950 - 1976
  • [27] Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
    Bak, Rasmus O.
    Dever, Daniel P.
    Reinisch, Andreas
    Hernandez, David Cruz
    Majeti, Ravindra
    Porteus, Matthew H.
    ELIFE, 2017, 6
  • [28] CRISPR-Cas9-based genetic engineering for crop improvement under drought stress
    Sami, Abdul
    Xue, Zhao
    Tazein, Saheera
    Arshad, Ayesha
    He Zhu, Zong
    Ping Chen, Ya
    Hong, Yue
    Tian Zhu, Xiao
    Jin Zhou, Ke
    BIOENGINEERED, 2021, 12 (01) : 5814 - 5829
  • [29] Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
    Roman Maresch
    Sebastian Mueller
    Christian Veltkamp
    Rupert Öllinger
    Mathias Friedrich
    Irina Heid
    Katja Steiger
    Julia Weber
    Thomas Engleitner
    Maxim Barenboim
    Sabine Klein
    Sandra Louzada
    Ruby Banerjee
    Alexander Strong
    Teresa Stauber
    Nina Gross
    Ulf Geumann
    Sebastian Lange
    Marc Ringelhan
    Ignacio Varela
    Kristian Unger
    Fengtang Yang
    Roland M. Schmid
    George S. Vassiliou
    Rickmer Braren
    Günter Schneider
    Mathias Heikenwalder
    Allan Bradley
    Dieter Saur
    Roland Rad
    Nature Communications, 7
  • [30] Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice
    Maresch, Roman
    Mueller, Sebastian
    Veltkamp, Christian
    Oellinger, Rupert
    friedrich, Mathias
    Heid, Irina
    Steiger, Katja
    Weber, Julia
    Engleitner, Thomas
    Barenboim, Maxim
    Klein, Sabine
    Louzada, Sandra
    Banerjee, Ruby
    Strong, Alexander
    Stauber, Teresa
    Gross, Nina
    Geumann, Ulf
    Lange, Sebastian
    Ringelhan, Marc
    Varela, Ignacio
    Unger, Kristian
    Yang, Fengtang
    Schmid, Roland M.
    Vassiliou, George S.
    Braren, Rickmer
    Schneider, Nter
    Heikenwalder, Mathias
    Bradley, Allan
    Saur, Dieter
    Rad, Roland
    NATURE COMMUNICATIONS, 2016, 7